ATE396733T1 - Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungen - Google Patents
Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungenInfo
- Publication number
- ATE396733T1 ATE396733T1 AT01271858T AT01271858T ATE396733T1 AT E396733 T1 ATE396733 T1 AT E396733T1 AT 01271858 T AT01271858 T AT 01271858T AT 01271858 T AT01271858 T AT 01271858T AT E396733 T1 ATE396733 T1 AT E396733T1
- Authority
- AT
- Austria
- Prior art keywords
- prophylactic
- therapeutic agents
- respiratory diseases
- inflammatory respiratory
- inflammatory
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000390941 | 2000-12-22 | ||
| PCT/JP2001/011264 WO2002051422A1 (fr) | 2000-12-22 | 2001-12-21 | Agents preventifs/remedes destines a des maladies inflammatoires des voies aeriennes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396733T1 true ATE396733T1 (de) | 2008-06-15 |
Family
ID=18857198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01271858T ATE396733T1 (de) | 2000-12-22 | 2001-12-21 | Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7214672B2 (de) |
| EP (1) | EP1344526B1 (de) |
| JP (1) | JP3691487B2 (de) |
| KR (1) | KR100833157B1 (de) |
| CN (2) | CN101518537A (de) |
| AR (2) | AR031969A1 (de) |
| AT (1) | ATE396733T1 (de) |
| CA (1) | CA2438799C (de) |
| DE (1) | DE60134267D1 (de) |
| DK (1) | DK1344526T3 (de) |
| ES (1) | ES2305029T3 (de) |
| MX (1) | MXPA03005660A (de) |
| PE (1) | PE20020793A1 (de) |
| PT (1) | PT1344526E (de) |
| TW (1) | TWI290145B (de) |
| WO (1) | WO2002051422A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0113042B8 (pt) * | 2000-08-05 | 2021-05-25 | Glaxo Group Ltd | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| BR0209271A (pt) * | 2001-04-30 | 2004-06-15 | Glaxo Group Ltd | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto |
| US20040248867A1 (en) * | 2001-06-12 | 2004-12-09 | Keith Biggadike | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| JP3691459B2 (ja) * | 2002-06-14 | 2005-09-07 | 久光メディカル株式会社 | 粉末状吸入剤組成物 |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| EP1645266A1 (de) * | 2004-10-08 | 2006-04-12 | Hisamitsu Medical Co., Ltd. | Wässrige Suspension für Nasentropfen |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| EP2111861A1 (de) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Zusammensetzungen von Phosphodiesterase-IV-Hemmern |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639434A (en) | 1967-02-02 | 1972-02-01 | Boots Pure Drug Co Ltd | 17-acyloxysteroids and their manufacture |
| SE418294B (sv) | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
| US4933168A (en) * | 1975-05-27 | 1990-06-12 | Syntex Pharmaceuticals International Limited | Stable, crystalline flunisolide |
| IL66432A0 (en) | 1981-08-04 | 1982-12-31 | Plurichemie Anstalt | Process for the preparation of steroidal esters |
| JPH07116215B2 (ja) * | 1989-04-19 | 1995-12-13 | エスエス製薬株式会社 | 新規なステロイド化合物 |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
-
2001
- 2001-12-21 TW TW090131849A patent/TWI290145B/zh not_active IP Right Cessation
- 2001-12-21 MX MXPA03005660A patent/MXPA03005660A/es active IP Right Grant
- 2001-12-21 ES ES01271858T patent/ES2305029T3/es not_active Expired - Lifetime
- 2001-12-21 PT PT01271858T patent/PT1344526E/pt unknown
- 2001-12-21 DE DE60134267T patent/DE60134267D1/de not_active Expired - Lifetime
- 2001-12-21 US US10/451,061 patent/US7214672B2/en not_active Expired - Lifetime
- 2001-12-21 CA CA002438799A patent/CA2438799C/en not_active Expired - Lifetime
- 2001-12-21 DK DK01271858T patent/DK1344526T3/da active
- 2001-12-21 CN CNA2009100064252A patent/CN101518537A/zh active Pending
- 2001-12-21 WO PCT/JP2001/011264 patent/WO2002051422A1/ja active IP Right Grant
- 2001-12-21 EP EP01271858A patent/EP1344526B1/de not_active Expired - Lifetime
- 2001-12-21 AT AT01271858T patent/ATE396733T1/de active
- 2001-12-21 CN CNA018210422A patent/CN1481246A/zh active Pending
- 2001-12-21 KR KR1020037007282A patent/KR100833157B1/ko active Protection Beyond IP Right Term
- 2001-12-21 JP JP2002552566A patent/JP3691487B2/ja not_active Expired - Lifetime
- 2001-12-26 AR ARP010106024A patent/AR031969A1/es not_active Application Discontinuation
- 2001-12-26 PE PE2001001303A patent/PE20020793A1/es not_active Application Discontinuation
-
2014
- 2014-09-23 AR ARP140103518A patent/AR097737A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1344526B1 (de) | 2008-05-28 |
| EP1344526A1 (de) | 2003-09-17 |
| EP1344526A4 (de) | 2005-03-16 |
| CA2438799C (en) | 2009-09-01 |
| DE60134267D1 (de) | 2008-07-10 |
| KR100833157B1 (ko) | 2008-05-28 |
| PE20020793A1 (es) | 2002-09-06 |
| CN1481246A (zh) | 2004-03-10 |
| DK1344526T3 (da) | 2008-09-15 |
| AR097737A2 (es) | 2016-04-13 |
| WO2002051422A1 (fr) | 2002-07-04 |
| CA2438799A1 (en) | 2002-07-04 |
| MXPA03005660A (es) | 2004-12-03 |
| ES2305029T3 (es) | 2008-11-01 |
| TWI290145B (en) | 2007-11-21 |
| CN101518537A (zh) | 2009-09-02 |
| JPWO2002051422A1 (ja) | 2004-04-22 |
| AR031969A1 (es) | 2003-10-08 |
| US20040053904A1 (en) | 2004-03-18 |
| JP3691487B2 (ja) | 2005-09-07 |
| US7214672B2 (en) | 2007-05-08 |
| PT1344526E (pt) | 2008-06-18 |
| KR20030064414A (ko) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE439844T1 (de) | Kombinationen für die behandlung entzündlicher erkrankungen | |
| PL362711A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| CY2014019I2 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
| DK1441713T3 (da) | Tamsulosin-tabletter med modificeret frigivelse | |
| DK1335678T3 (da) | Oralt behandlingssystem | |
| NO20034176L (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| ATE391531T1 (de) | Schweisshemmende mittel | |
| NO20031443L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| DE60134267D1 (de) | Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungen | |
| NO20040353L (no) | Ny terapeutsk metode | |
| DE60208982D1 (de) | Fussbad | |
| DE60009451D1 (de) | Massagegerät | |
| DE60222664D1 (de) | Hautbehandlungsmittel | |
| ATE343394T1 (de) | Endoparasitizide mittel | |
| DE60122111T8 (de) | Diaminotrifluormethylpyridinderivat enthaltendes therapeutisches oder prophylaktisches mittel für pulmonalinsuffizienz | |
| EP1444983A4 (de) | Mittel zur behandlung von entzündlichen darmerkrankungen | |
| PT1282599E (pt) | Derivados dissulfureto uteis para tratar doencas alergicas | |
| DE60220799D1 (de) | Hypoglykämisches mittel | |
| NO20032206L (no) | Kombinasjonsterapi for östrogen-avhengige forstyrrelser | |
| DE60108398D1 (de) | Kristallin-therapeutisches mittel | |
| DE60136966D1 (de) | Pflanzenstärkendes mittel | |
| DE60228736D1 (de) | Menschliches bmcc1-gen | |
| EP1426060A4 (de) | Mittel zur behandlung von allergischen erkrankungen | |
| SE0103854D0 (sv) | Therapeutic agents | |
| SE0103855D0 (sv) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1344526 Country of ref document: EP |